Australian researchers no longer need to wait. Retatrutide — one of the most-watched triple-receptor peptide compounds in recent research literature — is now available and in stock at Australian Peptides, ready for domestic dispatch across Australia this March 2026.

What Is Retatrutide?

Retatrutide (also known by its research designation LY3437943) is a next-generation multi-receptor agonist peptide developed for metabolic research. Where earlier generations of research peptides targeted a single pathway, retatrutide simultaneously engages three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and the glucagon receptor (GCGR).

This triple-agonist mechanism is what has made retatrutide a focal point in recent metabolic research. The simultaneous engagement of all three receptors is a distinguishing feature compared to dual-agonist compounds, and has driven significant scientific interest throughout 2024 and 2025.

March 2026: Retatrutide Stock Update

After strong demand through the close of 2025, we’re pleased to confirm that retatrutide is fully restocked as of March 2026. Current inventory covers multiple vial sizes to suit both small-scale preliminary investigations and larger research protocols.

Stock levels for high-demand peptides like retatrutide can move quickly. If you’ve been waiting on availability, now is the time to secure your research supply.

Why Australian Researchers Are Buying From Us

Sourcing high-quality research peptides from overseas has historically meant extended shipping timelines, unpredictable customs delays, and uncertainty around cold-chain integrity on arrival. Australian Peptides exists to solve exactly that problem.

• Domestic Australian stock — no international shipping delays or customs uncertainty
• Fast dispatch — orders processed and shipped within 24 hours of placement
• Research-grade quality with batch documentation available on request
• Cold-chain compliant packaging for peptide integrity on arrival
• Australian-based customer support for research sourcing questions

Other Peptides Available in March 2026

Alongside retatrutide, the current Australian Peptides catalogue includes a broad range of research compounds. Popular in-stock peptides this month include semaglutide, tirzepatide, BPC-157, TB-500 (Thymosin Beta-4), AOD-9604, and Ipamorelin/CJC-1295 blends.

Visit the store for the full catalogue with real-time stock status.

Buy Retatrutide Now

Retatrutide is in stock and dispatching within 24 hours. Shop now at australianpeptides.com.